cs231295
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 21, 2025 (NCT06902350)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06902350 | Phase 1 | May 21, 2025 | Capital Medical University, Chipscreen Biosciences, Ltd., Jilin Provincial Tumor Hospital |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Chipscreen Biosciences, Ltd. | For profit | 1 | 1 | 1 | 2025 |
| Jilin Provincial Tumor Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1